An Institutional Guide for Formulary Decisions of Biosimilars.

Ismail S, Abu Esba L, Khan M, Al-Abdulkarim H, Modimagh H, Yousef C

DOI: 10.1177/00185787221138007
Published: 2023 Feb
Container: Hospital pharmacy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/00185787221138007,
  title = {An Institutional Guide for Formulary Decisions of Biosimilars.},
  author = {Ismail S and Abu Esba L and Khan M and Al-Abdulkarim H and Modimagh H and Yousef C},
  year = {2023},
  journal = {Hospital pharmacy},
  doi = {10.1177/00185787221138007},
  url = {https://doi.org/10.1177/00185787221138007}
}

RIS

TY  - JOUR
TI  - An Institutional Guide for Formulary Decisions of Biosimilars.
AU  - Ismail S
AU  - Abu Esba L
AU  - Khan M
AU  - Al-Abdulkarim H
AU  - Modimagh H
AU  - Yousef C
PY  - 2023
JO  - Hospital pharmacy
DO  - 10.1177/00185787221138007
UR  - https://doi.org/10.1177/00185787221138007
ER  -

APA

S, I., L, A. E., M, K., H, A., H, M., & C, Y. (2023). An Institutional Guide for Formulary Decisions of Biosimilars.. Hospital pharmacy. https://doi.org/10.1177/00185787221138007

Source records

pubmed · retrieved 2026-09-25T17:08:13.728Z
europe-pmc · retrieved 2026-09-25T17:08:13.763Z